Blood test may predict heart attack risk in fatty liver patients

NCT ID NCT07487571

First seen Mar 30, 2026 · Last updated Apr 28, 2026 · Updated 5 times

Summary

This study looks at whether a routine blood test called mean platelet volume (MPV) can help predict acute coronary syndrome (heart attack or unstable angina) in people with metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers will compare MPV levels between 60 adults: those with both MASLD and a recent heart event, and those with MASLD alone. The goal is to see if MPV is a useful early warning sign.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES (ACS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sohag University Hospital

    Sohag, Sohag Governorate, Egypt

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.